Growth Metrics

Aurinia Pharmaceuticals (AUPH) Depreciation & Amortization (CF) (2015 - 2026)

Aurinia Pharmaceuticals posted quarterly Depreciation & Amortization (CF) of $4.8 million for Q1 2026, down 0.82% year-on-year from $4.9 million in Q1 2025, and down 0.99% on a QoQ basis from $4.9 million in Q4 2025.

Aurinia Pharmaceuticals (AUPH) has 12 years of Depreciation & Amortization (CF) data on file, last reported at $4.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 0.82% year-over-year to $4.8 million; the trailing twelve-month figure through Mar 2026 stood at $19.4 million (changed 0.23% YoY), and the FY2025 full-year result was $19.4 million, changed 0.02% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $4.8 million, down from $4.9 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $5.3 million in Q3 2023 and bottomed at -$6.1 million in Q4 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $4.8 million (2024), against an average of $2.6 million.
  • The widest annual swing landed in 2023, when Depreciation & Amortization (CF) plunged 223.16%; it then jumped 576.01% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at -$1.9 million in 2022, then slumped by 223.16% to -$6.1 million in 2023, then surged by 179.73% to $4.9 million in 2024, then gained by 0.04% to $4.9 million in 2025, then decreased by 0.99% to $4.8 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $4.8 million (Q1 2026), $4.9 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 1,395.22
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 55.90 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 123.20 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 13.55 Mn
10 Aurinia Pharmaceuticals 2.03 Bn 1.65 Bn 71.20 Mn 4.82 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.82 Mn
Mar 31, 2026 4.82 Mn
Dec 31, 2025 4.86 Mn
Dec 31, 2025 4.86 Mn
Sep 30, 2025 4.87 Mn
Sep 30, 2025 4.87 Mn
Jun 30, 2025 4.86 Mn
Jun 30, 2025 4.86 Mn
Mar 31, 2025 4.86 Mn
Mar 31, 2025 4.86 Mn
Dec 31, 2024 4.86 Mn
Dec 31, 2024 4.86 Mn
Sep 30, 2024 4.89 Mn
Sep 30, 2024 4.89 Mn
Jun 30, 2024 4.84 Mn
Jun 30, 2024 4.84 Mn
Mar 31, 2024 4.85 Mn
Mar 31, 2024 4.85 Mn
Dec 31, 2023 -6.10 Mn
Dec 31, 2023 -6.10 Mn
Sep 30, 2023 5.26 Mn
Sep 30, 2023 5.26 Mn
Jun 30, 2023 719,000.00
Jun 30, 2023 719,000.00
Mar 31, 2023 717,000.00
Mar 31, 2023 717,000.00
Dec 31, 2022 -1.89 Mn
Dec 31, 2022 -1.89 Mn
Sep 30, 2022 1.11 Mn
Sep 30, 2022 1.11 Mn
Jun 30, 2022 687,000.00
Jun 30, 2022 687,000.00
Mar 31, 2022 687,000.00
Mar 31, 2022 687,000.00
Dec 31, 2021 -1.37 Mn
Dec 31, 2021 -1.37 Mn
Sep 30, 2021 200,000.00
Sep 30, 2021 200,000.00
Jun 30, 2021 200,000.00
Jun 30, 2021 200,000.00
Mar 31, 2021 688,000.00
Mar 31, 2021 688,000.00
Dec 31, 2020 -18,000.00
Dec 31, 2020 -18,000.00
Jun 30, 2020 145,000.00
Jun 30, 2020 145,000.00
Mar 31, 2020 55,000.00
Mar 31, 2020 55,000.00
Dec 31, 2019 42,000.00
Dec 31, 2019 42,000.00
Sep 30, 2019 41,000.00
Sep 30, 2019 41,000.00
Jun 30, 2019 38,000.00
Jun 30, 2019 38,000.00
Mar 31, 2019 37,000.00
Mar 31, 2019 37,000.00
Dec 31, 2018 6,000.00
Dec 31, 2018 6,000.00
Sep 30, 2018 5,000.00
Sep 30, 2018 5,000.00
Jun 30, 2018 6,000.00
Jun 30, 2018 6,000.00
Mar 31, 2018 3,000.00
Mar 31, 2018 3,000.00
Dec 31, 2017 5,000.00
Dec 31, 2017 5,000.00
Sep 30, 2017 5,000.00
Sep 30, 2017 5,000.00
Jun 30, 2017 6,000.00
Jun 30, 2017 6,000.00
Mar 31, 2017 6,000.00
Mar 31, 2017 6,000.00
Sep 30, 2016 5,000.00
Sep 30, 2016 5,000.00
Jun 30, 2016 5,000.00
Jun 30, 2016 5,000.00
Mar 31, 2016 5,000.00
Mar 31, 2016 5,000.00
Sep 30, 2015 5,000.00
Sep 30, 2015 5,000.00
Jun 30, 2015 5,000.00
Jun 30, 2015 5,000.00